Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naive settings. Garcia JS, Flamand Y, Penter L, Keng M, et al. Blood 2023;141:1884-1888.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Garcia JS, Flamand Y, Penter L, Keng M, et al. Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naive settings. Blood 2023;141:1884-1888.
PMID: 36332187